| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |